Biogen (BIIB) Other financing activities (2009 - 2026)

Biogen has reported Other financing activities for 18 years, with the latest figure at -$13.3 million in Q2 2026.

• On a quarterly basis, Other financing activities fell 1008.33% year-over-year to -$13.3 million in Q2 2026; TTM through Jun 2026 was $2.9 million, a 135.8% increase from a year earlier, with the FY2025 full-year figure at $5.0 million, up 327.27% from the prior year.
• Other financing activities was -$13.3 million for Q2 2026 at Biogen, down from $11.3 million in the prior quarter.
• The five-year high for Other financing activities was $16.5 million in Q1 2023, with the low at -$14.8 million in Q2 2023.
• Average Other financing activities over 5 years is $1.4 million, with a median of $1.9 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2026: Other financing activities surged 3950.0% in 2023, then tumbled 1008.33% in 2026.
• Over 5 years, Other financing activities stood at $200000.0 in 2022, then soared by 3950.0% to $8.1 million in 2023, then sank by 45.68% to $4.4 million in 2024, then plunged by 129.55% to -$1.3 million in 2025, then tumbled by 923.08% to -$13.3 million in 2026.
• The last three Other financing activities figures came in at -$13.3 million (Q2 2026), $11.3 million (Q1 2026), and -$1.3 million (Q4 2025), per Business Quant data.